AMN Healthcare Services, Inc.
NYSE:AMNMedical - Care Facilities
-$1.29 today
- Market cap
- $1.45B
- Beta
- 0.44
- P/E (TTM)
- -37.3
- EPS (TTM)
- -$0.83
Volume 0.55M
Average 1.02M
AMN Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
AMN Healthcare Services, Inc.NYSE: AMN
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin widens to 4.5%
Net margin was 4.5% in Q1 FY2026, up 4.7 pp from a year earlier. On a trailing-twelve-month basis it was -0.9%, up 4.8 pp year over year. Over 3 fiscal years it narrowed by 12.0 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 6 analysts of 4.8% for the fiscal year ending Dec 2026, up from -3.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 4.5%+5.5 pp QoQ
- Last fiscal yearDec 2025
- -3.5%+1.4 pp YoY
- LTMMar 2026
- -0.9%+4.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.7 pp | +18.9 pp | +14.2 pp |
| 1 year | +1.4 pp | +8.3 pp | +6.9 pp |
| 3 years | -12.0 pp | +5.4 pp | +17.4 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -3.5%
- Year-over-year change
- +1.4pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -3.5% | +1.4pp |
| FY2024 | 2024-12-31 | -4.9% | -10.5pp |
| FY2023 | 2023-12-31 | 5.6% | -2.9pp |
| FY2022 | 2022-12-31 | 8.5% | +0.3pp |
| FY2021 | 2021-12-31 | 8.2% | — |
Net Margin vs competitors
How AMN compares with its peers on the latest reported figures
- AMN's LTM Mar 2026 net margin of -0.9% is the 3rd highest of the 9 companies compared; the peer median is -31.7%.
- Its year-over-year change of +4.8 pp is the 2nd highest of 9, against a peer median of +0.0 pp.
- Over three fiscal years its change of -12.0 pp compares with a peer median of +1.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 11.0% | +0.2 pp | +201.8 pp | |
| LTM Mar 2026 | 6.4% | -0.1 pp | +1.5 pp | |
| LTM Mar 2026 | -0.9% | +4.8 pp | -12.0 pp | |
| LTM Mar 2026 | -7.4% | +2.6 pp | +1.0 pp | |
| LTM Mar 2026 | -26.3% | -21.7 pp | -27.1 pp | |
| LTM Jun 2026 | -37.1% | +53.1 pp | -95.3 pp | |
| LTM Mar 2026 | -48.2% | -36.0 pp | -27.9 pp | |
| LTM Mar 2026 | -73.6% | +1.9 pp | +150.9 pp | |
| LTM Mar 2026 | -215.4% | -16.6 pp | +256.8 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding AMN) | -31.7% | +0.0 pp | +1.3 pp | |
Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.98B | 5.24B | 3.79B | 2.98B | 2.73B |
| Cost of Revenue | 2.67B | 3.53B | 2.54B | 2.06B | 1.96B |
| Gross Profit | 1.31B | 1.72B | 1.25B | 919.38M | 774.06M |
| Gross Margin | 32.9% | 32.7% | 33.0% | 30.8% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 730.45M | 936.58M | 756.24M | 632.49M | 593.02M |
| Operating Expenses | 831.6M | 1.07B | 911.15M | 1.02B | 740.89M |
| Depreciation & Amortization | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M |
| EBITDA | 581.7M | 784.21M | 499.36M | 71.11M | 101.13M |
| EBITDA Margin | 14.6% | 15.0% | 13.2% | 2.4% | 3.7% |
| Operating Income | 478M | 647.1M | 338.43M | (102.67M) | 33.17M |
| Operating Margin | 12.0% | 12.3% | 8.9% | -3.4% | 1.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.08M | 40.4M | 54.14M | 69.9M | 45.59M |
| Other Income / Expenses | (34.08M) | (40.4M) | (54.14M) | (69.9M) | (134.23M) |
| Income Before Tax | 443.92M | 606.7M | 284.29M | (172.57M) | (101.06M) |
| Pre-Tax Margin | 11.1% | 11.6% | 7.5% | -5.8% | -3.7% |
| Income Tax Expense | 116.53M | 162.65M | 73.61M | (25.6M) | (5.36M) |
| Net Income | 327.39M | 444.05M | 210.68M | (146.98M) | (95.7M) |
| Net Margin | 8.2% | 8.5% | 5.6% | -4.9% | -3.5% |
| EPS (Basic) | 6.87 | 9.96 | 5.38 | (3.85) | (2.48) |
| EPS (Diluted) | 6.81 | 9.90 | 5.36 | (3.85) | (2.48) |
| Weighted Avg Shares | 47.69M | 44.59M | 39.17M | 38.19M | 38.52M |
| Weighted Avg Shares (Diluted) | 48.05M | 44.87M | 39.34M | 38.19M | 38.52M |
AMN Healthcare Services, Inc.
NYSE:AMN
Intrinsic Alpha fair value
Locked
Current Price
$37.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.